<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-90982</identifier>
<setSpec>0300-8932</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Diagnostic accuracy of NT-proBNP compared with electrocardiography in detecting left ventricular hypertrophy of hypertensive origin</dc:title>
<dc:description xml:lang="en">Electrocardiography (ECG) is the most widely used method for diagnosing left ventricular hypertrophy (LVH) in hypertensive patients. We assessed the value of N-terminal pro-brain natriuretic peptide (NT-proBNP) determination compared with ECG for detecting LVH in 336 consecutive hypertensive patients with preserved systolic function. We found a significant correlation between NT-proBNP levels and left ventricular mass adjusted for body surface area (r=.41; P&lt;.001). The area under the receiver operating characteristic curve was 0.75 (95% CI, 0.7-0.8). A cut-off of 74.2 pg/mL had a greater sensitivity than ECG (76.6% vs 25.5%; P&lt;.001) and a higher negative predictive value (87.8% vs 76.6%; P&lt;.001) in the identification of LVH. NT-proBNP determination may be a useful tool for LVH screening in hypertensive patients (AU)</dc:description>
<dc:creator>Roldán, Julián</dc:creator>
<dc:creator>Morillas, Pedro</dc:creator>
<dc:creator>Mateo, Irene</dc:creator>
<dc:creator>Andrade, Helder</dc:creator>
<dc:creator>Castillo, Jesús</dc:creator>
<dc:creator>Agudo, Pilar</dc:creator>
<dc:creator>Bertomeu-Martínez, Vicente</dc:creator>
<dc:creator>Quiles, Juan</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El electrocardiograma (ECG) es el método más utilizado para el diagnóstico de hipertrofia ventricular izquierda (HVI) en pacientes hipertensos. Analizamos la utilidad del propéptido natriurético cerebral N-terminal (NT-proBNP) en la identificación de HVI comparado con el ECG en 336 pacientes hipertensos consecutivos con función sistólica conservada. Se encontró una correlación significativa entre concentración de NT-proBNP y masa ventricular izquierda ajustada por superficie corporal (r=0,41; p&lt;0,001). El área bajo la curva receiver operating characteristic fue de 0,75 (intervalo de confianza del 95%, 0,7-0,8). Un punto de corte de 74,2 pg/ml presentaba una sensibilidad superior que el ECG (el 76,6 frente al 25,5%; p&lt;0,001) y un mayor valor predictivo negativo (el 87,8 frente al 76,6%; p&lt;0,001) en la identificación de HVI. El NT-proBNP puede ser una buena herramienta en el cribado de HVI en pacientes hipertensos (AU)</dc:description>
<dc:source>Rev Esp Cardiol;64(10): 939-941, oct. 2011. tab, ilus</dc:source>
<dc:identifier>ibc-90982</dc:identifier>
<dc:title xml:lang="es">Validez diagnóstica del NT-proBNP frente al electrocardiograma en la detección de hipertrofia ventricular izquierda de origen hipertensivo</dc:title>
<dc:subject>^d4634^s22045</dc:subject>
<dc:subject>^d8657^s22045</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d7152^s22012</dc:subject>
<dc:subject>^d29310</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d24584</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d38110</dc:subject>
<dc:subject>^d30693^s29166</dc:subject>
<dc:subject>^d30693^s22032</dc:subject>
<dc:subject>^d7152^s22016</dc:subject>
<dc:subject>^d30693^s22012</dc:subject>
<dc:subject>^d28606</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d53386</dc:subject>
<dc:subject>^d4634^s22074</dc:subject>
<dc:type>article</dc:type>
<dc:date>201110</dc:date>
</metadata>
</record>
</ibecs-document>
